SunPharm, Warner-Lambert deal

SUNP received a six-figure payment from partner Warner-Lambert, representing partial payment of a $1 million milestone that was due upon completion of the company's on-going Phase I trials of diethylnorspermine (DENSPM), a polyamine analog, in cancer. SUNP had $1.1 million in cash as of March 31. ...